Skip to main content
Top
Published in: The Journal of Headache and Pain 2/2010

Open Access 01-04-2010 | Original Article

Long-term effects of a sensitisation campaign on migraine: the Casilino study

Authors: B. Petolicchio, L. Di Clemente, M. Altieri, E. Vicenzini, G. L. Lenzi, Vittorio Di Piero

Published in: The Journal of Headache and Pain | Issue 2/2010

Login to get access

Abstract

In 2003, we conducted a sensitisation campaign on migraine in the Casilino district of Rome, by sending a letter with the ID Migraine test to all the households and placing posters in the GPs’ waiting room. Out of 195 headache patients recruited, 92% had migraine while 73% had never consulted a physician for headache. The aim of this study was to evaluate the long-term impact of this campaign. The follow-up was performed by a telephone interview. The questionnaire considered the characteristics of headache, quality of life, preventive and acute treatments, drug efficacy, comorbidity and subjective usefulness of the campaign. Of the 179 migraineurs, 90.5% (mean age 40.7 ± 16.5, 139 females) were included in the follow-up. An improvement was observed in mean pain intensity (−13.9%; p < 0.0001) and mean HIT-6 score (−6.1%; p = 0.0003). The campaign was considered to be useful by 63.6% of cases, while 66.1% reported an improvement in their clinical status. Improved patients showed a decreased mean number of days with headache per month (−51.7%; p < 0.0001), pain intensity (−21.8%; p < 0.0001), headache duration (−18.1%; p = 0.0008) and HIT-6 score (−11.7%; p < 0.0001). Our data suggest that the effects of a “single shot” campaign are beneficial not only in a short-term perspective, but even in the long term. Moreover, the lack of benefit in more severe cases suggests that such patients should not be treated by GPs alone: patients in whom the HIT-6 score, frequency, severity or duration of headache worsen should be promptly referred to the headache clinic.
Literature
1.
go back to reference Roncolato M, Fabbri L, Recchia G, Cavazzuti L, Visona G, Brignoli O, Medea G (2000) An epidemiology study to assess migraine. Prevalence in a sample of italian population presenting to their GPs. Eur Neurol 43:102–106 10.1159/000008143, 1:STN:280:DC%2BD3c7ltlCntg%3D%3D, 10686468CrossRefPubMed Roncolato M, Fabbri L, Recchia G, Cavazzuti L, Visona G, Brignoli O, Medea G (2000) An epidemiology study to assess migraine. Prevalence in a sample of italian population presenting to their GPs. Eur Neurol 43:102–106 10.1159/000008143, 1:STN:280:DC%2BD3c7ltlCntg%3D%3D, 10686468CrossRefPubMed
2.
go back to reference Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF (2002) Migraine in the United States: epidemiology and patterns of health care use. Neurology 58:885–894 1:STN:280:DC%2BD387ot1Wqtw%3D%3D, 11914403CrossRefPubMed Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF (2002) Migraine in the United States: epidemiology and patterns of health care use. Neurology 58:885–894 1:STN:280:DC%2BD387ot1Wqtw%3D%3D, 11914403CrossRefPubMed
3.
go back to reference Bigal ME, Lipton RB, Stewart WF (2004) The epidemiology and impact of migraine. Curr Neurol Neurosci Rep 4:98–104 10.1007/s11910-004-0022-8, 14984680CrossRefPubMed Bigal ME, Lipton RB, Stewart WF (2004) The epidemiology and impact of migraine. Curr Neurol Neurosci Rep 4:98–104 10.1007/s11910-004-0022-8, 14984680CrossRefPubMed
4.
go back to reference Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429–440 10.1007/s10194-005-0252-4, 16388337PubMedCentralCrossRefPubMed Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s Classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429–440 10.1007/s10194-005-0252-4, 16388337PubMedCentralCrossRefPubMed
5.
go back to reference Steiner TJ (2005) Lifting the burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain 6:373–377 10.1007/s10194-005-0241-7, 16362709PubMedCentralCrossRefPubMed Steiner TJ (2005) Lifting the burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain 6:373–377 10.1007/s10194-005-0241-7, 16362709PubMedCentralCrossRefPubMed
6.
go back to reference Di Piero V, Altieri M, Conserva G, Petolicchio B, di Clemente L, Hettiarachchi J General Practitioner’s Co-operative of the Casilino district of Rome (2007) The effects of a sensitisation campaign on unrecognised migraine: the Casilino study. J Headache Pain 8:205–208 Di Piero V, Altieri M, Conserva G, Petolicchio B, di Clemente L, Hettiarachchi J General Practitioner’s Co-operative of the Casilino district of Rome (2007) The effects of a sensitisation campaign on unrecognised migraine: the Casilino study. J Headache Pain 8:205–208
7.
go back to reference Lipton RB, Dodick D, Sadovsky R et al (2003) A self-administered screener for migraine in primary care: the ID Migraine(TM) validation study. Neurology 61:375–382 1:STN:280:DC%2BD3sznslOrtA%3D%3D, 12913201CrossRefPubMed Lipton RB, Dodick D, Sadovsky R et al (2003) A self-administered screener for migraine in primary care: the ID Migraine(TM) validation study. Neurology 61:375–382 1:STN:280:DC%2BD3sznslOrtA%3D%3D, 12913201CrossRefPubMed
8.
go back to reference Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1–96 Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1–96
9.
go back to reference Lantéri-Minèt M, Auray JP, Hasnaoui A, Dartigues JF, Duru G, Henry P, Lucas C, Predalier A, Chazot G, Gaudin AF (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143–149 10.1016/s0304-3959(02)00348-2, 12620605CrossRefPubMed Lantéri-Minèt M, Auray JP, Hasnaoui A, Dartigues JF, Duru G, Henry P, Lucas C, Predalier A, Chazot G, Gaudin AF (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102:143–149 10.1016/s0304-3959(02)00348-2, 12620605CrossRefPubMed
10.
go back to reference Lipton RB, Stewart WF, Liberman J (2002) Self-awareness of migraine. Interpreting the labels that headache sufferers apply to their headaches. Neurology 58(9 Suppl 6):S21–S26 12011270CrossRefPubMed Lipton RB, Stewart WF, Liberman J (2002) Self-awareness of migraine. Interpreting the labels that headache sufferers apply to their headaches. Neurology 58(9 Suppl 6):S21–S26 12011270CrossRefPubMed
11.
go back to reference Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657 10.1046/j.1526-4610.2001.041007646.x, 1:STN:280:DC%2BD3MrhtVKjtg%3D%3D, 11554952CrossRefPubMed Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646–657 10.1046/j.1526-4610.2001.041007646.x, 1:STN:280:DC%2BD3MrhtVKjtg%3D%3D, 11554952CrossRefPubMed
12.
go back to reference Lipton RB, Diamond S, Reed M, Diamond M, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41:638–645 10.1046/j.1526-4610.2001.041007638.x, 1:STN:280:DC%2BD3MrhtVKjsQ%3D%3D, 11554951CrossRefPubMed Lipton RB, Diamond S, Reed M, Diamond M, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41:638–645 10.1046/j.1526-4610.2001.041007638.x, 1:STN:280:DC%2BD3MrhtVKjsQ%3D%3D, 11554951CrossRefPubMed
13.
go back to reference Sheftell FD, Tepper SJ, Bigal ME (2005) Migraine: barriers for care. Neurol Sci 26:S140–S142 10.1007/s10072-005-0428-3, 15926013CrossRefPubMed Sheftell FD, Tepper SJ, Bigal ME (2005) Migraine: barriers for care. Neurol Sci 26:S140–S142 10.1007/s10072-005-0428-3, 15926013CrossRefPubMed
14.
go back to reference Lipton RB, Bigal ME, Amatniek JC, Stewart WF (2004) Tools for diagnosing for migraine measuring its severity. Headache 44:387–398 10.1111/j.1526-4610.2004.04089.x, 15147245CrossRefPubMed Lipton RB, Bigal ME, Amatniek JC, Stewart WF (2004) Tools for diagnosing for migraine measuring its severity. Headache 44:387–398 10.1111/j.1526-4610.2004.04089.x, 15147245CrossRefPubMed
15.
go back to reference Martelletti P, Haimanot RT, Lainez MJ, Rapaport AM, Ravishankar K, Sakai F, Silberstein SD, Vincent M, Steiner TJ (2005) The Global Campaign (GC) to reduce the burden of headache worldwide. The International Team for Specialist Education (ITSE). J Headache Pain 6:261–263 10.1007/s10194-005-0202-1, 16362681PubMedCentralCrossRefPubMed Martelletti P, Haimanot RT, Lainez MJ, Rapaport AM, Ravishankar K, Sakai F, Silberstein SD, Vincent M, Steiner TJ (2005) The Global Campaign (GC) to reduce the burden of headache worldwide. The International Team for Specialist Education (ITSE). J Headache Pain 6:261–263 10.1007/s10194-005-0202-1, 16362681PubMedCentralCrossRefPubMed
16.
go back to reference Campinha-Bacote DL, Kendle JB, Jones C, Callicoat D, Webert A, Stoukides CA, Kaul AF (2005) Impact of a migraine management on improving health outcomes. Dis Manag 8:382–391 10.1089/dis.2005.8.382, 16351556CrossRefPubMed Campinha-Bacote DL, Kendle JB, Jones C, Callicoat D, Webert A, Stoukides CA, Kaul AF (2005) Impact of a migraine management on improving health outcomes. Dis Manag 8:382–391 10.1089/dis.2005.8.382, 16351556CrossRefPubMed
17.
go back to reference Rothrock JF, Parada VA, Sims C, Key K, Walters NS, Zweifler RM (2006) The impact of intensive patient education on clinical outcome in a clinic-based migraine-population. Headache 46:726–731 10.1111/j.1526-4610.2006.00428.x, 16643574CrossRefPubMed Rothrock JF, Parada VA, Sims C, Key K, Walters NS, Zweifler RM (2006) The impact of intensive patient education on clinical outcome in a clinic-based migraine-population. Headache 46:726–731 10.1111/j.1526-4610.2006.00428.x, 16643574CrossRefPubMed
18.
go back to reference Blumenfeld A, Tischio M (2003) Center of excellence for headache care: group model at Kaiser Permanente. Headache 43:431–440 10.1046/j.1526-4610.2003.03087.x, 12752747CrossRefPubMed Blumenfeld A, Tischio M (2003) Center of excellence for headache care: group model at Kaiser Permanente. Headache 43:431–440 10.1046/j.1526-4610.2003.03087.x, 12752747CrossRefPubMed
19.
go back to reference Harpole L, Samsa G, Jurgelski AE, Shipley JL, Bernstein A, Matchar DB (2003) Headache management program improves outcome for chronic headache. Headache 43:715–724 10.1046/j.1526-4610.2003.03128.x, 12890125CrossRefPubMed Harpole L, Samsa G, Jurgelski AE, Shipley JL, Bernstein A, Matchar DB (2003) Headache management program improves outcome for chronic headache. Headache 43:715–724 10.1046/j.1526-4610.2003.03128.x, 12890125CrossRefPubMed
20.
go back to reference Karli N, Zarifoglu M, Erer S, Pala K, Akis N (2006) The impact of education on the diagnostic accuracy of tension type headache and migraine: a prospective study. Cephalalgia 27:41–45 10.1111/j.1468-2982.2006.01245.xCrossRef Karli N, Zarifoglu M, Erer S, Pala K, Akis N (2006) The impact of education on the diagnostic accuracy of tension type headache and migraine: a prospective study. Cephalalgia 27:41–45 10.1111/j.1468-2982.2006.01245.xCrossRef
21.
go back to reference Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM (1997) Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group. Neurology 49:1219–1225 1:CAS:528:DyaK2sXnslylsrc%3D, 9371897CrossRefPubMed Solomon GD, Cady RK, Klapper JA, Earl NL, Saper JR, Ramadan NM (1997) Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group. Neurology 49:1219–1225 1:CAS:528:DyaK2sXnslylsrc%3D, 9371897CrossRefPubMed
22.
go back to reference Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 55:19–26 10.1002/ana.10786, 1:CAS:528:DC%2BD2cXhtVOnu7g%3D, 14705108CrossRefPubMed Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 55:19–26 10.1002/ana.10786, 1:CAS:528:DC%2BD2cXhtVOnu7g%3D, 14705108CrossRefPubMed
23.
go back to reference Burstein R, Jakubowski M (2004) Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 55:27–36 10.1002/ana.10785, 1:CAS:528:DC%2BD2cXhtVOnu7k%3D, 14705109CrossRefPubMed Burstein R, Jakubowski M (2004) Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 55:27–36 10.1002/ana.10785, 1:CAS:528:DC%2BD2cXhtVOnu7k%3D, 14705109CrossRefPubMed
24.
go back to reference Silberstein SD, Dodick D, Kesslick J (2005) Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size. Headache 45:1250–1254 10.1111/j.1526-4610.2005.00250.x, 16178957CrossRefPubMed Silberstein SD, Dodick D, Kesslick J (2005) Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size. Headache 45:1250–1254 10.1111/j.1526-4610.2005.00250.x, 16178957CrossRefPubMed
25.
go back to reference Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans in migraine: detailed and methods of a meta-analysis pf 53 trial. Cephalalgia 22:633–658 10.1046/j.1468-2982.2002.00404.x, 1:STN:280:DC%2BD38njtlehtw%3D%3D, 12383060CrossRefPubMed Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans in migraine: detailed and methods of a meta-analysis pf 53 trial. Cephalalgia 22:633–658 10.1046/j.1468-2982.2002.00404.x, 1:STN:280:DC%2BD38njtlehtw%3D%3D, 12383060CrossRefPubMed
26.
go back to reference Lucas C, Auray JP, Gaudin AF, Dartigues JF, Duru G, Henry P, Lantéri-Minet M, Pradalier A, Charzot G, El Hasnaoui A (2004) Use and misuse of triptans in France: data from the GRIM 2000 population survey. Cephalalgia 24:197–205 10.1111/j.1468-2982.2003.00651.x, 1:STN:280:DC%2BD2c7js1OqsA%3D%3D, 15009013CrossRefPubMed Lucas C, Auray JP, Gaudin AF, Dartigues JF, Duru G, Henry P, Lantéri-Minet M, Pradalier A, Charzot G, El Hasnaoui A (2004) Use and misuse of triptans in France: data from the GRIM 2000 population survey. Cephalalgia 24:197–205 10.1111/j.1468-2982.2003.00651.x, 1:STN:280:DC%2BD2c7js1OqsA%3D%3D, 15009013CrossRefPubMed
27.
go back to reference Donnet A, Lantéri-Minèt M, Géraud G, Guegan-Massardier E, Demarquay G, Giraud P, Lucas C, Valade D (2009) Impact of a public sensitization campaign on migraine management in France. J Headache Pain 10:241–247 10.1007/s10194-009-0128-0, 19484351PubMedCentralCrossRefPubMed Donnet A, Lantéri-Minèt M, Géraud G, Guegan-Massardier E, Demarquay G, Giraud P, Lucas C, Valade D (2009) Impact of a public sensitization campaign on migraine management in France. J Headache Pain 10:241–247 10.1007/s10194-009-0128-0, 19484351PubMedCentralCrossRefPubMed
28.
go back to reference Panconesi A, Pavone E, Vacca F, Vaiani M, Banfi R (2008) Triptans in the Italian population: a drug utilization and literature review. J Headache Pain 9:71–76 10.1007/s10194-008-0020-3, 18317865PubMedCentralCrossRefPubMed Panconesi A, Pavone E, Vacca F, Vaiani M, Banfi R (2008) Triptans in the Italian population: a drug utilization and literature review. J Headache Pain 9:71–76 10.1007/s10194-008-0020-3, 18317865PubMedCentralCrossRefPubMed
29.
go back to reference Cevoli S, D’Amico D, Martelletti P, Valguarnera F, Del Bene E, De Simone R, Sarchielli P, Narbone MC, Testa L, Genco S, Bussone G, Cortelli P (2009) Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 29:1285–1293 10.1111/j.1468-2982.2009.01874.x, 1:STN:280:DC%2BD1MjktlGjsA%3D%3D, 19438916CrossRefPubMed Cevoli S, D’Amico D, Martelletti P, Valguarnera F, Del Bene E, De Simone R, Sarchielli P, Narbone MC, Testa L, Genco S, Bussone G, Cortelli P (2009) Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 29:1285–1293 10.1111/j.1468-2982.2009.01874.x, 1:STN:280:DC%2BD1MjktlGjsA%3D%3D, 19438916CrossRefPubMed
Metadata
Title
Long-term effects of a sensitisation campaign on migraine: the Casilino study
Authors
B. Petolicchio
L. Di Clemente
M. Altieri
E. Vicenzini
G. L. Lenzi
Vittorio Di Piero
Publication date
01-04-2010
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue 2/2010
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1007/s10194-009-0183-6

Other articles of this Issue 2/2010

The Journal of Headache and Pain 2/2010 Go to the issue